Altimmune Inc.

ALT | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.27

+$0.02 (+0.62%)

At close: Sep 21, 2026, 4:00 PM ET

$3.39

+$0.12 (+3.67%)

Pre-market: Sep 22, 2026, 8:54 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-88.09M	-95.06M	-88.45M	-84.71M	-97.09M	-49.04M
Depreciation & Amortization	112K	238K	477K	493K	551K	428.88K
Stock-Based Compensation	16.08M	14.39M	10.64M	8.1M	5.52M	2.58M
Other Working Capital	2.19M	4.6M	-3.23M	8.04M	-8.21M	5.62M
Other Non-Cash Items	-1.7M	-3.9M	9.79M	-578K	13.03M	16.25M
Deferred Income Tax	-681K	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	6.75M	4.48M	-8.27M	14.11M	-251K	-4.51M
Operating Cash Flow	-67.54M	-79.85M	-75.81M	-62.59M	-78.24M	-34.31M
Capital Expenditures	-11K	n/a	-47K	-126K	-12.31M	-342.42K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-285.45M	-115.73M	-88.63M	-73.27M	-7.59M	-128.29M
Sales Maturities Of Investments	152.99M	87.35M	102.41M	n/a	107.43M	56.41M
Other Investing Acitivies	n/a	n/a	n/a	n/a	-195K	-138.46K
Investing Cash Flow	-132.47M	-28.39M	13.73M	-73.4M	87.52M	-72.23M
Debt Repayment	33.92M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-709K	50K	-496K	434K	58K	41.17M
Financial Cash Flow	206.84M	10.04M	86.11M	56.78M	65.1M	213.49M
Net Cash Flow	6.83M	-98.19M	24.03M	-79.2M	74.38M	106.96M
Free Cash Flow	-67.55M	-79.85M	-75.86M	-62.71M	-90.55M	-34.65M
Adj. Free Cash Flow	-83.62M	-94.24M	-86.5M	-70.81M	-96.07M	-37.22M
Maintenance CapEx	-2.44K	n/a	n/a	-126K	-12.31M	-40.34K
Growth CapEx	-8.56K	n/a	-47K	n/a	n/a	-302.08K
Owner Earnings	-67.54M	-79.85M	-75.81M	-62.71M	-90.55M	-34.35M